How have NTRBW shares performed in 2024?

Nutriband's stock was trading at $0.36 at the beginning of the year. Since then, NTRBW shares have increased by 233.3% and is now trading at $1.1999. View the best growth stocks for 2024 here .

How do I buy shares of Nutriband?

Shares of NTRBW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:NTRBW

Nutriband (NTRBW) Stock Price, News & Analysis

→ Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem (From Weiss Ratings) (Ad)

Free NTRBW Stock Alerts

$1.20

+0.04 (+3.44%)

(As of 01:41 PM ET)

Compare

Today's Range: $1.10
▼
$1.33
50-Day Range: $0.25
▼
$1.23
52-Week Range: $0.19
▼
$2.11

Volume: 5,367 shs
Average Volume: 12,302 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Trends

Get Nutriband alerts:

Ad Weiss Ratings

Nvidia is Pivoting to Solve Big Tech’s $1 Trillion Problem

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

About Nutriband Stock (NASDAQ:NTRBW)

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.

NTRBW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NTRBW Stock News Headlines

May 3, 2024 | investorplace.com

NTRB Stock Earnings: Nutriband Reported Results for Q4 2023

See More Headlines

Receive NTRBW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: NASDAQ:NTRBW
CUSIP: N/A
CIK: 1676047
Web: nutriband.com
Phone: 14073776695
Fax: N/A
Employees: 7
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $2.09 million
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Mr. Serguei Melnik (Age 50)
Founder, President, Company Secretary & Executive Chairman of the Board
Comp: $175k
Mr. Gareth Sheridan (Age 34)
Founder, CEO & Director
Comp: $175k
Mr. Gerald Goodman (Age 76)
CFO & Chief Accounting Officer
Comp: $140k
Dr. Alan Smith Ph.D. (Age 58)
COO & President of 4P Therapeutics
Comp: $159k
Dr. Jeffrey Patrick Pharm.D. (Age 54)
Chief Scientific Officer
Mr. Michael Myer (Age 39)
President of Pocono Pharmaceutical
Comp: $40.6k
Mr. Tyler Overk (Age 40)
Head of Active Intelligence

Key Competitors

View All Competitors

NTRBW Stock Analysis - Frequently Asked Questions

How have NTRBW shares performed in 2024?: Nutriband's stock was trading at $0.36 at the beginning of the year. Since then, NTRBW shares have increased by 233.3% and is now trading at $1.1999.
View the best growth stocks for 2024 here.
How do I buy shares of Nutriband?: Shares of NTRBW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NTRBW) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial